We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+7.47%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$56.6B
AUM Growth
+$2.63B
Cap. Flow
-$307M
Cap. Flow %
-0.54%
Top 10 Hldgs %
29.54%
Holding
969
New
110
Increased
283
Reduced
395
Closed
105

Top Buys

Rank Stock Value
1
HES
Hess
HES
+$292M
2
MMM icon
3M
MMM
+$186M
3
BMY icon
Bristol-Myers Squibb
BMY
+$170M
4
WM icon
Waste Management
WM
+$146M
5
DOV icon
Dover
DOV
+$143M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$199M
2
CSX icon
CSX Corp
CSX
+$197M
3
DE icon
Deere & Co
DE
+$122M
4
COP icon
ConocoPhillips
COP
+$110M
5
RBA icon
RB Global
RBA
+$109M

Sector Composition

Rank Sector Weight
1 Technology 28.49%
2 Healthcare 16.13%
3 Financials 10.57%
4 Consumer Discretionary 9.62%
5 Industrials 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAIA icon
801
Saia
SAIA
$9.65B
$981K ﹤0.01%
+2,243
New +$950K
LZM.WS icon
802
Lifezone Metals Ltd Warrants
LZM.WS
$27.4M
$979K ﹤0.01%
1,231,797
ALK icon
803
Alaska Air
ALK
$5.66B
$904K ﹤0.01%
20,000
FLYW icon
804
Flywire
FLYW
$2.25B
$901K ﹤0.01%
55,000
-120,000
-69% -$2.1M
OS
805
DELISTED
OneStream Inc
OS
$848K ﹤0.01%
+25,000
New +$737K
QXO
806
QXO Inc
QXO
$16.4B
$791K ﹤0.01%
+50,148
New +$1.46M
SGML icon
807
Sigma Lithium
SGML
$1.21B
$662K ﹤0.01%
+53,575
New +$585K
TNYA icon
808
Tenaya Therapeutics
TNYA
$157M
$626K ﹤0.01%
324,245
-675,755
-68% -$1.91M
EWTX icon
809
Edgewise Therapeutics
EWTX
$4.78B
$574K ﹤0.01%
21,509
-28,088
-57% -$559K
CMRX
810
DELISTED
Chimerix, Inc.
CMRX
$558K ﹤0.01%
600,000
PTEN icon
811
Patterson-UTI
PTEN
$3.83B
$536K ﹤0.01%
70,000
+20,000
+40% +$184K
BSY icon
812
Bentley Systems
BSY
$10.7B
$508K ﹤0.01%
+10,000
New +$492K
CMS icon
813
CMS Energy
CMS
$22.3B
$463K ﹤0.01%
6,561
-279,900
-98% -$18.4M
ZPTA
814
DELISTED
Zapata Computing Holdings Inc. Common Stock
ZPTA
$461K ﹤0.01%
+1,700,000
New +$851K
CDTX
815
DELISTED
Cidara Therapeutics
CDTX
$460K ﹤0.01%
+42,755
New +$513K
SHMD
816
SCHMID Group
SHMD
$292M
$446K ﹤0.01%
125,000
OPAL icon
817
OPAL Fuels
OPAL
$72.6M
$420K ﹤0.01%
115,000
CRVO icon
818
CervoMed
CRVO
$25.6M
$418K ﹤0.01%
28,600
-11,433
-29% -$177K
ALHC icon
819
Alignment Healthcare
ALHC
$2.78B
$355K ﹤0.01%
30,000
-110,000
-79% -$1.04M
FARM
820
DELISTED
Farmer Brothers
FARM
$339K ﹤0.01%
171,229
-50,000
-23% -$128K
ANTX icon
821
AN2 Therapeutics
ANTX
$219M
$334K ﹤0.01%
312,615
BOLT icon
822
Bolt Biotherapeutics
BOLT
$7.44M
$324K ﹤0.01%
25,000
TENX icon
823
Tenax Therapeutics
TENX
$498M
$288K ﹤0.01%
+83,333
New +$302K
CRGY icon
824
Crescent Energy
CRGY
$3.74B
$274K ﹤0.01%
+25,000
New +$286K
GNRC icon
825
Generac Holdings
GNRC
$12.5B
$263K ﹤0.01%
+1,658
New +$246K

Similar funds

Adage Capital Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Adage Capital Partners held 969 positions worth $56.6B, up 4.9% from $54B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Adage Capital Partners's Q3 2024 filing shows 110 new, 283 increased, 395 reduced and 105 closed positions. Its largest new stake was EQT Corp: 2,636,935 shares worth $96.6M. The largest sale was Merck, an estimated $199M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q3 2024 buy was EQT Corp: 2,636,935 shares worth $96.6M.
  • Adage Capital Partners added most to Hess in Q3 2024, an estimated $292M increase.
  • Adage Capital Partners's biggest Q3 2024 reduction was Merck, cutting an estimated $199M.
  • Adage Capital Partners fully exited Deere & Co in Q3 2024, selling an estimated $122M.
  • Adage Capital Partners's ten largest holdings make up 30% of its $56.6B portfolio in Q3 2024.
  • Adage Capital Partners opened 110 new positions and closed 105 in Q3 2024.
  • Adage Capital Partners's portfolio value rose 4.9% quarter-over-quarter to $56.6B.

Based on Adage Capital Partners's 13F filing for Q3 2024, filed 14 Nov 2024.